The week in health tech, explained in plain English.Get the free newsletter →
October 1, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

UnitedHealth Faces IRS Probe Over Foreign Subsidiary Transfers

UnitedHealth Group is under IRS scrutiny for transactions involving its foreign subsidiaries, a dispute that could sharply raise the insurer's tax bill, according to STAT News. The probe centers on how the company moved value across international units, a practice known as transfer pricing that multinational firms use to allocate income and expenses between jurisdictions with different tax rates.

The core question is whether those transfers were structured to reduce what UnitedHealth owed in US taxes. If the IRS concludes the arrangements understated the company's domestic income, UnitedHealth could face a substantial back-tax obligation plus potential penalties.

The scrutiny lands as UnitedHealth, the largest US health insurer and parent of Optum, is already navigating regulatory and legal pressure on multiple fronts. Transfer-pricing disputes are common among large multinationals and often stretch on for years before resolution, so any final financial impact may not be clear for some time.

Sources

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.